<?xml version="1.0" encoding="UTF-8"?>
<ref id="irv12664-bib-0068">
 <label>68</label>
 <mixed-citation publication-type="journal" id="irv12664-cit-0068">
  <string-name>
   <surname>Mossler</surname>
   <given-names>C</given-names>
  </string-name>, 
  <string-name>
   <surname>Groiss</surname>
   <given-names>F</given-names>
  </string-name>, 
  <string-name>
   <surname>Wolzt</surname>
   <given-names>M</given-names>
  </string-name>, 
  <string-name>
   <surname>Wolschek</surname>
   <given-names>M</given-names>
  </string-name>, 
  <string-name>
   <surname>Seipelt</surname>
   <given-names>J</given-names>
  </string-name>, 
  <string-name>
   <surname>Muster</surname>
   <given-names>T</given-names>
  </string-name>. 
  <article-title>Phase I/II trial of a replication‐deficient trivalent influenza virus vaccine lacking NS1</article-title>. 
  <source xml:lang="en">Vaccine</source>. 
  <year>2013</year>;
  <volume>31</volume>:
  <fpage>6194</fpage>‐
  <lpage>6200</lpage>.
  <pub-id pub-id-type="pmid">24183981</pub-id>
 </mixed-citation>
</ref>
